A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

NCT03663946 · clinicaltrials.gov ↗

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Cell Carcinoma
Kidney Cancer

Interventions

OTHER: Non-Interventional

Sponsor

Bristol-Myers Squibb